Mgo One Seven LLC Regeneron Pharmaceuticals, Inc. Transaction History

Mgo One Seven LLC

$2.26 Billion
Q3 2024

A detailed history of Mgo One Seven LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Mgo One Seven LLC holds 386 shares of REGN stock, worth $274,986. This represents 0.02% of its overall portfolio holdings.

Number of Shares

386

Previous 436 11.47%

Holding current value

$274,986

Previous $458,000 11.57%

% of portfolio

0.02%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$1024.09 - $1201.76 $51,204 - $60,088	-50 Reduced 11.47%	386 $405,000
Q2 2024 Aug 07, 2024	BUY	$883.2 - $1071.19 $30,912 - $37,491	35 Added 8.73%	436 $458,000
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $73,117 - $80,461	81 Added 25.31%	401 $385,000
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $58,138 - $66,127	75 Added 30.61%	320 $281,000
Q3 2023 Nov 03, 2023	BUY	$692.45 - $844.37 $169,650 - $206,870	245 New	245 $201,000
Q1 2023 May 08, 2023	BUY	$680.49 - $826.97 $214,354 - $260,495	315 New	315 $258,000
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $324,867 - $409,965	-566 Reduced 70.4%	238 $823,000
Q2 2022 Aug 10, 2022	BUY	$548.35 - $738.84 $440,873 - $594,027	804 New	804 $475,000
Q3 2020 Oct 30, 2020	SELL	$544.75 - $658.21 $175,409 - $211,943	-322 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$493.32 - $643.92 $158,849 - $207,342	322 New	322 $201,000
Q1 2019 Apr 09, 2019	SELL	$372.08 - $439.57 $87,438 - $103,298	-235 Closed	0 $0
Q4 2018 Jan 24, 2019	BUY	$335.82 - $403.04 $78,917 - $94,714	235 New	235 $87,000
Q3 2018 Oct 09, 2018	SELL	$351.14 - $408.51 $53,724 - $62,502	-153 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $8,842 - $11,025	-28 Reduced 15.47%	153 $53,000
Q4 2017 Feb 16, 2018	BUY	$358.63 - $469.95 $64,912 - $85,060	181	181 $68,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mgo One Seven LLC with notifications on news.

Account